TrialCancer research and treatment2017

ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer.

Ji-Youn Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.